Abel Tesfai (PhD)

ARANOTE trial data suggests treatment intensification i.e. Darolutamide and ADT in metastatic hormone-sensitive prostate cancer setting, is safe and efficacious for Black men (who made up around 10% of total trial population): auajournals.org/doi/10.1097/... #prostatecancer #healthinequalities

Keir Starmer to scrap NHS England and bring health service back under 'democratic control' - live updates The PM says abolishing

A step backwards www.bbc.co.uk/news/live/cx...

Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in E... International guidelines recommend treatment intensification combining docetaxel or androgen receptor pathway inhibitors with androgen deprivation the…

Excellent paper by the National Prostate Cancer Audit team www.sciencedirect.com/science/arti...

Award details | Funding and scholarships for students | University of Exeter

Interesting PhD opportunity from the University of Exeter to conduct ecological research on River Thames under supervision from Lead Supervisor Dr Sarah Nelms with aim to improve participation by Black British students www.exeter.ac.uk/study/fundin... #PhD #diversity #PhD

www.mrcctu.ucl.ac.uk/news/news-st...

Health Inequities Conference Join our free online conference on Thursday 13 March to learn more about the latest data and evidence from the National Prostate Cancer Audit report

Our final agenda & speaker lineup for our fully online Prostate Cancer UK conference "Towards Equity: Exploring Prostate Cancer Disparities in Black Men" is now live!
🗓️ Thursday 13 March 2025 |⏰ 1:30-4:30 PM GMT
📢 More info here bit.ly/3QfzSAV and on registration
#ProstateCancer #HealthEquity

HESA Spring 2025: staff Working in the higher education sector has become more precarious than ever. David Kernohan tracks the changes through the data

Great reporting by Wonkhe as usual: wonkhe.com/blogs/hesa-s...

BJGP Top 10 Research 2024

No. 3 #BJGPTop10 – Prostate cancer detection: Clinical consensus challenges UK guidelines and recommends proactive discussion of PSA testing with higher-risk men
doi.org/10.3399/BJGP...

@abel5.bsky.social @andrewseggie.bsky.social @vincentjgnana.bsky.social

Residential Segregation and Racial Cancer Disparities: A Systematic Review - PubMed Empirical analysis of segregation and racial cancer disparities is a recent area of research. The literature is limited to 17 studies that focused primarily on breast cancer. Studies differed in their...

Interesting old US study on the role of racial residential segregation in cancer incidence, mortality, survival, risk, screening, and/or stage at diagnosis - further development in measure of segregation needed pubmed.ncbi.nlm.nih.gov/28039602/ #healthinequalities

Real-World Evidence for Health Equity in Prostate Cancer Awards We want to stop prostate cancer being a killer. We fund groundbreaking research, drive improvements in treatment, and fight injustice in care.

🌟 Exciting Announcement! 🌟

We are pleased to announce Prostate Cancer UK's Real-World Evidence Funding Call has launched with opporunity to submit proposals focusing on Black men and deprivation! 🚀

prostatecanceruk.org/research/for...

️ 🗓️ Expressions of Interest open on 1st February 2025.

⏰Join us for our online public mini conference at Prostate Cancer UK: 'Towards Equity: Exploring Prostate Cancer Disparities Experienced by Black Men'.

🗓️ Date: Thursday, 13 March 2025, 1:30-4:30pm (GMT)

🖊️ Registration Link: lnkd.in/etzZD62K

See: lnkd.in/eiHqg6MA

Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards - PubMed In the USA, Black men are approximately twice as likely to be diagnosed with and to die of prostate cancer than white men. In the UK, despite Black men having vastly different ancestral contexts and h...

A really insightful paper exploring racial/ethnic disparities in prostate cancer outcome in both US and UK pubmed.ncbi.nlm.nih.gov/39424981/